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Abstract: Fer kinase, a protein involved in the regulation of cell-cell adhesion and proliferation,
has been shown to be required during invertebrate development and has been implicated in leukemia,
gastric cancer, and liver cancer. However, in vivo roles for Fer during vertebrate development have
remained elusive. In this study, we bridge the gap between the invertebrate and vertebrate realms by
showing that Fer kinase is required during zebrafish embryogenesis for normal hematopoiesis
and vascular organization with distinct kinase dependent and independent functions. In situ
hybridization, quantitative PCR and fluorescence activated cell sorting (FACS) analyses revealed
an increase in both erythrocyte numbers and gene expression patterns as well as a decrease in the
organization of vasculature endothelial cells. Furthermore, rescue experiments have shown that
the regulation of hematopoietic proliferation is dependent on Fer kinase activity, while vascular
organizing events only require Fer in a kinase-independent manner. Our data suggest a model in
which separate kinase dependent and independent functions of Fer act in conjunction with Notch
activity in a divergent manner for hematopoietic determination and vascular tissue organization.
Keywords: non-receptor tyrosine kinase; erythrocyte; vasculature; embryogenesis
1. Introduction
The formation of germ layers during vertebrate development leads to increasing levels of
molecular fine tuning that result in the differentiation of specific tissue types. Proper differentiation
relies heavily on transcriptional regulation and cellular adhesion, both of which are mediated by
different types of kinase signaling. Kinase signaling during development has been well characterized
and involves myriad kinases, including both receptor and non-receptor tyrosine kinases, such as
the well-known Src family kinases (reviewed in [1–3]). Additionally, the emergence of the dualistic
properties of some kinases has revealed novel avenues of protein functions which will further clarify
complex signaling roles in cellular regulation.
One subset of non-receptor tyrosine kinases (NRTKs) is the Fes/Fps family that includes the Fer
(Fes-Related) kinase. Fer kinase expression was first detected in both human and mouse (leukemic
and erythroblast) cells [4], and has been shown to be highly conserved throughout evolution [5,6].
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Fer kinase contains an N-terminal F-BAR domain, shown to be involved in stabilizing interactions with
cytoskeletal elements that recruit Fer to the plasma membrane, a Src homology 2 (SH2) domain and a
tyrosine kinase (TyrKin) domain [7]. Additionally, Fer also has a coiled-coil domain that facilitates
homotypic oligomerization and autophosphorylation by forming homotrimers, which are not required
for kinase activity [8]. Fer has been shown to be activated via pathways, such as epidermal growth
factor receptor (EGFR) and platelet derived growth factor (PDGF), and phosphorylate protein targets,
such as Stat3 [9–14]. However, the required in vivo functions of Fer during development remain
largely unknown.
Fer kinase is conserved across invertebrate and vertebrate phyla. For example, Fer expression has
been detected in sea sponges [15], nematodes [16], fruit flies [17,18], rats and humans [6]. In vertebrates,
two versions of Fer have been observed in mice and humans, the full length version, found ubiquitously
expressed, and a testis specific version, arising from an internal start site [6,19]. Interestingly, there is
greater variability among invertebrates regarding different versions of Fer, such that while fruit
flies have been shown to express both versions [18]; nematodes only express the truncated, but not
the full length, version of Fer [16]. Recently, the full length version of Fer has been shown to be
expressed during zebrafish development in a ubiquitous manner early, while later concentrating
to the head region and fin buds [20]. In addition, the same study reported developmental defects
ranging from convergent extension to craniofacial defects when knocking down Fer using morpholino
technology [20].
Fer kinase has been linked to a variety of cellular functions, such as cytoskeletal interactions,
mediating cadherin and integrin dependent adhesion that can lead to cellular migration [21–23].
Interestingly, the absence of Fer kinase has been shown to lead to developmental defects during
embryonic enclosure in nematodes [16] and fruit flies [24], both of which are cadherin dependent
adhesion functions of Fer. Fer kinase has also been shown to be involved in cellular proliferation under
normal conditions in human and worms [25–27]. Importantly, Fer kinase has been reported to regulate
cancer progression where it appears to be functioning in a finely tuned balance, such that when either
over-expressed in renal cell carcinomas [28,29] or deleted in myeloid leukemia [30] or lung cancer [31],
the cellular functions of Fer are perturbed and result in similar negative consequences (such as loss of
cadherin-complex stability). Furthermore, an RNA interference screen effectively demonstrated that
Fer kinase plays a significant role in cancer cell survival, and also that the loss of Fer enhanced cell
death in conjunction with chemotherapeutic agents [32].
More recently, kinase inactive protein functions have been reported, showing that there are
critical aspects of kinases that do not require their phosphorylation capacity to be intact (reviewed
in [3]). Kinase independent roles for Fer have been demonstrated, due to the sustained viability and
fertility of mice expressing a kinase inactive version of Fer [12], as well as the ability of a similar
kinase inactivating mutations in Fer to rescue embryonic development in nematodes [16]. Interestingly,
both Fer and Fes/Fps have been reported to be redundant in regulating hematopoiesis [33]. Parsing out
the functions of Fer that are independent of kinase activity will shed more light on the complexities of
the signaling pathways involved, and may allow for more clarification on overlapping roles within the
Fes-Fps subfamily of NRTKs.
In this study, we characterized a novel expression pattern and functional component to Fer during
zebrafish embryonic development, which has not previously reported. We report here that not only is
Fer required for proper axis determination and formation of head structures during embryogenesis
(as reported by [20], but also for proper organization of the vascular endothelium and hematopoietic
proliferation in the trunk region. The absence of Fer results in disorganized trunk vasculature within
the region of the cardinal vein (CV), dorsal aorta (DA) and intersegmental vessels (ISV), resulting in
subsequent loss of erythrocyte circulation. Additionally, we observed an increase in hematopoietic cell
markers in the region of the intermediate cell mass (ICM), corresponding to an increase in the number
of erythrocytes. Finally, we demonstrated diverging roles for Fer, with Fer kinase activity required for
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the proper proliferation of hematopoietic cell populations, but a kinase independent role in proper
organization of the vascular endothelium via the Notch pathway.
2. Materials and Methods
2.1. Transgenic Zebrafish Lines
Wildtype (AB) zebrafish as well as lines expressing either fli1a::nEGFP (y7Tg) or gata1a::dsRed
(sd2Tg) were obtained from the Zebrafish International Resource Center (Eugene, OR, USA), from which
we generated a stable fli1a::nEGFP (y7Tg), gata1a::dsRed (sd2Tg) double transgenic line. All lines were
maintained according to standard zebrafish husbandry protocols, as previously described [34].
2.2. Fer Morpholino Knockdown
Antisense morpholino oligonucleotides (MOs) were generated by Gene Tools, LLC (Philomath,
OR, USA). fer-MO1 (5′-CTGGAAGAGAGACAGAGATCACACT-3′) was designed against the splice
acceptor site in intron 8 of fer in order to prevent proper splicing with exon 9, thus facilitating an
exon-8-10 splice, generating a premature stop codon in the translated product. The control morpholino
was a 25-mer of randomized nucleotides purchased from Gene Tools, LLC. The oligonucleotides
were solubilized in RNase-free water at a concentration of 1 mM and stored according to the
manufacturer’s instructions. The injections were made by diluting the oligonucleotides with
phenol red and RNase-free water. Titration of the morpholino was achieved by injecting 1nL at
concentrations from 0.25 mM (2 ng/nL) to 0.5 mM (4 ng/nL) to determine the optimum level
for microinjection (which was 0.5 mM). An exception to this is the MO concentration used in the
tubulogenesis/circulation experiments with Rhodamine–Dextran was 0.25 mM. The Fer rescue
experiments were performed by injecting 1 nL of 0.5 mM fer-MO1 and control MO. Improper
splicing with the fer MO was confirmed using PCR to amplify the region spanning exon 9, using a
forward primer in exon 8 (5′-AGTCCACCACAGAGGAGCTG-3′) and a reverse primer in exon 10
(5′-AGTCTGTCCTTGGCTCTTCG-3′) (Figure 2I). Although not shown here, experiments repeated with
MOs and PCR primers, as reported by Paardekooper Overman, et al. (P-O MO), confirmed specificities
for the Fer gene were consistent with data obtained using our fer-MO1 (Fer protein knockdown with
both MOs is shown in Supplementary Figure S1 as fer-MO1 and P-O MO) [20]. Morpholino knockdown
was confirmed using a Western blot analysis, using an anti-Fer monoclonal antibody (Cell Signaling).
2.3. Whole Mount In Situ Hybridization (WISH)
Embryos were collected and fixed in 4% PFA overnight at 4 ◦C before performing WISH,
as previously described [35]. Probes for fer, fli1, gata1, scl, c-myb, hbbe2, and runx1 were generated from
linearized plasmid containing the cDNA of interest, using either T7 or SP6 RNA polymerase (Ambion)
and digoxygenin-UTP labeling mix (Roche). The embryos were washed in a series of glycerol/PBS
solutions, where the percent glycerol was increased from 30 to 70 percent, prior to mounting on slides
and imaging.
2.4. o-Dianisidine Staining
Control and fer-MO1 embryos were collected and dechorionated at the desired developmental
stages. They were then immediately stained for approximately 30 min in a fresh solution of 0.6 mg/mL
o-dianisidine, 0.01 M sodium acetate (pH 4.5), 0.65% H2O2, and 40% ethanol. After staining, they were
cleared with a solution of 2:1 benzyl benzoate/benzyl alcohol.
2.5. Microangiography
At 48 h post-fertilization (hpf), fer-MO1 and control embryos (using the fli1a::nEGFP transgenic
line) were anesthetized and mounted in low-melting agarose. They were then injected in the dorsal
aorta (trunk region at the posterior end of the yolk extension) or the sinus venosus with 1 nL of a
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12 nM solution of red fluorescent Rhodamine–Dextran beads (70,000 MW, Molecular Probes, Eugene,
OR, USA) and given 15–20 min for the beads to circulate prior to imaging.
2.6. Quantitative PCR (qPCR)
Using a QIAGEN RNeasy kit, the total RNA of control and fer-MO1 injected embryos was isolated
at the indicated time points and then reverse transcribed to cDNA using a FirstChoice RLM RACE
kit (Ambion), which was used in all subsequent PCR reactions. Primer pairs for kdrl/flk1, fli1, gata1,
scl, runx1, notch1b, c-myb, hbbe2 and fer were designed using Primer3 and chosen to have fragment
size between 150 and 200 base pairs (Supplemental Table S1). qPCR was performed using a SsoFast
EvaGreen Supermix (BioRad) and a C1000 thermocycler with the CFX96 Real Time System (BioRad).
Experiments were repeated twice, with gene targets analyzed in triplicate with each run. A melt curve
was used to confirm the purity of the analyzed product. The analysis was performed by normalizing
the target genes to actin.
2.7. Fluorescence Activated Cell Sorting (FACS)
Zebrafish embryos that were injected with fer-MO1 or control MO were collected at 28 hpf and
subjected to cell dissociation and resuspended in PBS, as previously described [36]. Cells were sorted
on a BD FACS Caliber flow cytometer (BD Biosciences, San Jose, CA, USA) using FL3 to determine
gata1::dsRed fluorescence, and FL1 to determine fli1a::nEGFP fluorescence. Cells were gated by nEGFP
or dsRed signal using CellQuest Pro to determine the number of gata1 and fli1a expressing cells in
each sample. At least 10,000 cells were counted per treatment and the experiment was repeated twice,
with error determined via calculation of the standard deviation.
2.8. Fer Kinase Inactivating Point Mutations and Notch Rescue Experiments
Point mutations in fer were generated separately in the SH2 and tyrosine kinase domains of the
zebrafish Fer with a cloned full length cDNA (clone ID:7060149 from Open Biosystems-Dharmacon,
Lafayette, CO, USA) using the QuikChange Lightning Site-Directed Mutagenesis kit (Agilent) and
the sequence confirmed (Figure 7O). The plasmids were linearized with NotI and capped mRNA
(including point mutants, wildtype and anti-sense) was made using the SP6 mMessage mMachine kit
(Ambion). Approximately 25 pg of mRNA was co-injected with 0.25 mM MO (fer-MO1 or control MO).
The zebrafish Notch Intracellular Domain (NICD) construct was obtained (Addgene, Cambridge, MA,
USA, 453 pCSMTN5ICD was a gift from Nathan Lawson, plasmid # 22466)) and capped mRNA made
using the SP6 mMessage mMachine kit. NICD expression was confirmed by Western blot analysis,
using an anti-activated Notch antibody (AbCam).
2.9. Imaging
All imaging was performed on either a Nikon SMZ1500 dissecting microscope, an inverted,
epifluorescent Zeiss Apotome microscope or a laser scanning confocal microscope (Nikon A1R and
Leica SPE). (Nikon, Tokyo, Japan) (Zeiss, Oberkochen, Germany) (Leica, Wetzlar, Germany).
Three dimensional (3D) reconstructions were obtained by mounting embryos at 28 hpf in low
melting agarose and these were imaged following stimulation with the 488 nm and 561 nm diode
lasers, using a Plan Apo λ 20x objective. Mounted embryos were placed on the stage of the Nikon A1
microscope within an Okolab stage-top incubation system that maintained a temperately controlled
environment of 28.5 ◦C. A NIS Elements (Nikon) device was used to visualize the zebrafish embryos
and perform 3D reconstructions (from z-stacks).
Biology 2017, 6, 40 5 of 20
3. Results
3.1. Fer Kinase Is Expressed during Embryogenesis
Using the predicted amino acid sequence of the zebrafish Fer, we compared Fer homologues
among a wide variety of organisms, ranging from invertebrates to vertebrates (Figure 1A). The resulting
phylogenetic analysis showed that the zebrafish Fer is 74 percent homologous to the human Fer,
being conserved throughout the F-Bar, FX, SH2 and tyrosine kinase domains, thus serving as an
important “bridge” between the invertebrate and vertebrate versions of Fer. We generated gene specific
probes to fer cDNA for in situ hybridization, to determine the spatio-temporal expression during
development. Similar to what was reported by Paardekooper Overman et al. [20], we found fer to be
expressed ubiquitously until approximately ten somites, when it became more specifically concentrated
toward the head region. However, we also observed fer expression in the primordial region of the dorsal
aorta (DA)/cardinal vein (CV), when compared to a fer antisense probe negative control (In Figure 1B,C,
respectively—24 hpf is shown). This expression pattern decreased in intensity until approximately 72
hpf, when fer expression was no longer detectable in the ICM region. Confirmation by quantitative
PCR showed highest expression of fer early in development, which decreased until 24 hpf, when it
appeared to stabilize at a level three to four-fold lower than the earliest expression (Figure 1D).
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Figure 1. Fer kinase is conserved throughout evolution and is expressed during zebrafish
embryogenesis. The zebrafish homologue of Fer kinase is highly conserved throughout eukaryotic
organisms and contains the same domains as the human version (A). The zebrafish homologue of
the fer kinase gene is expressed ubiquitously during early developmental stages with more specific
xpression merging b tween 24 and 72 hpf (not shown). At 24 hpf, fer expression is bserved in
the interm diate cell mass (ICM) an developing brain region (B), when compared t a fer anti-sense
probe (C). Quantitative P R shows f r xpression is highest during early development and tapers off
by 24 hpf to three to four-fold l er levels (D).
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3.2. Fer Kinase Is Required for Proper Blood and Vasculature Development in Zebrafish
The requirement for the zebrafish Fer kinase homologue during development was examined using
knockdown with gene specific morpholinos (see methods). In the absence of Fer kinase, we observed
the arrest of embryonic development at 72 hpf, with severe defects in hematopoiesis, vasculogenesis,
heart development and the central nervous system. In the absence of Fer kinase, at 30 somites (~28 hpf)
we observed a lack of circulating blood cells (Figure 2A, Supplemental Video S1 when compared to
control MO injected embryos (Figure 2C, Supplemental Video S2; this was emphasized by the absence
or pooling of hematopoietic cells in the region of the ICM. All embryos were imaged after reaching the
same stage, which, in the absence of Fer kinase, resulted in a shortening of the anterior–posterior axis,
similar to what was observed by Paardekooper Overman et al. [20]. In addition to the lack of circulating
erythrocytes, the absence of Fer kinase activity led to general cardiac development defects, along with
pericardial edema (Figure 2B,F, Supplemental Video S3 when compared to wildtypes (Figure 2D,H,
Supplemental Video S4. In Fer deficient embryos, the heart chambers both contracted, although in
the majority of embryos, the heart chamber contraction occurred erratically and asynchronously,
when compared with wildtypes. In this study we therefore chose to focus our investigation on the
hematopoietic and vascular defects.
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Figure 2. Fer knockdown results in apparent vasculature blockage and accumulation of developing
hematopoietic cells. At 30 somites, fer-MO1 embryos exhibit convergence extension defects along the
anterior–posterior axis with red blood cells that are pooled in the posterior ICM region (A) with none
present in the pumping heart (B), when compared to wildtypes ((C,D) respectively). By 48 hpf, the lack
of circulating ed blood cells and mpty heart chambers is emphasized in the Fer knoc d wn embryos
(E,F) compared to wildtype embryos (G,H). Agarose gel electrophoresis f fer-reverse transcription
PCR f om fer-MO1 injected embryos to demonstrate the blockage of Fer splicing at exo 9 (I).
We found there were two categories of severity in the loss of circulation in fer-MO1 injected
embryos, with 78.4 percent of embryos containing primarily non-circulating erythrocytes and 21.6
percent of embryos containing no visibly circulating erythrocytes (n = 223). A loss of circulating
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erythrocyte populations was observed in control MO injected embryos less than one percent of the
time (n = 258). In the category containing non-circulating erythrocytes, the fer-MO1 phenotype became
more pronounced by 48 hpf (Figure 2E), with the group of non-circulating erythrocytes expanding
in number in the region of the ICM, compared to the control MO embryos, where no non-circulating
erythrocytes were observed (Figure 2G).
To confirm that the cells present were differentiated erythroid cells, we performed o-dianisidine
staining, which labels erythrocyte populations expressing hemoglobin. The loss of Fer kinase resulted
in decreased erythrocytes in the anterior region and visible pooling of cells in the posterior (ICM)
region of the embryo at 28 hpf (Figure 3A,C, control embryos Figure 3B,D, n = 25 per condition).
At 48 and 72 hpf, erythrocytes in the fer-MO1 embryos were present in the anterior region, due to the
normal production of erythrocytes that occurs during this time from the aorta-gonad-mesonephros
(AGM). However, in the most severe embryos (lacking Fer activity), there was still no detection of
hemoglobin containing cells in the posterior trunk region during these time points (Figure 3E,G, n = 25
per condition). In contrast, control MO injected embryos contained erythrocytes throughout their
entire circulatory system (Figure 3F,H). Normally, by 48 hpf, erythrocytes are no longer produced in
the region of the ICM, thus the lack of trunk staining of the fer-MO1 embryos at 48 and 72 hpf suggests
the absence of circulation rather than an inhibition of erythrocyte development at the later time points.
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Figure 3. The loss of Fer kinase function res lt i the lo s of early ante ior erythrocyte formation
and the loss f circulation. o-Dianisidin i g showed the slightly igh r levels of erythrocyte
heme groups in the posterior trunk region f f - 1 embryos at 30 somites (~28 hpf) (C, control-D),
but not in the anterior (A), as is observed in control e bryos (B). The staining was no longer present
in the posterior region at 48 and 72 hpf in fer-MO1 ((E,G) respectively) but regained anterior staining,
indicating that later erythrocyte production is functional but no circulation is taking place (control
F and H, 48 and 72 hpf respectively).
To bet r visu lize the defects in erythrocyte circulation i the absence of Fer kinase we ge erated
a stable fli1a::nEGFP, gata-1::dsRed double tra sgenic lin to observ both vascular and hematopoietic
cells in the same embryos. Using this model, in the absence of Fer activity, we observed a lack of
organization within the region forming the dorsal aorta and the cardinal vein, as well as a significant
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loss of ISV formation (i.e., decrease in the number of fli1a::nEGFP migrating cells) at both 30 somites
(~28 hpf) and 48 hpf in 82.1 percent of the embryos (n = 56)(Figure 4A,B), when compared to the control
embryos where no loss of vascular organization was observed in any embryos (n = 47) (Figure 4E,F).
Additionally, we found that in embryos with disorganized vasculature, there was a corresponding
abundance of gata1::dsRed expressing cells in the region of the ICM. However, these gata1::dsRed cells
were completely stationary, with no observable movement into the ISVs (Figure 4C,D show punctate
dots); which is in contrast to the control embryos, where cells could be observed moving within the
dorsal aorta (Figure 4G,H—static images, lack of puncta in H indicates circulating cells).
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Figure 4. The loss of Fer kinase function resulted in intersegmental vessel (ISV) formation defects and
loss of blood flow in zebrafish embryos. fer-MO1 injected embryos failed to properly organize the dorsal
aorta (DA) and cardinal vein (CV) regions (A,B), and had fewer ISV structures form (white arrowheads),
when compared to the control MO injected embryos (E,F). Additionally, at similar time points in the
absence o F r kinase, hematopoietic precursor cells formed in the region of the DA but failed to circulate
(C,D) (control MO—(G,H)). Vasculature was visualized using fli1::nEGFP and hematopoietic cells were
visualized using gata1::dsRed. In (C,D,G,H), punctate dots indicate stationary cells, while continuous
lines indicate moving cells. Time points are at 30 somites (~28 hpf) for (A,C,E,G) and 48 hpf for
(B,D,F,H). (Note: some cells in appe r overexposed due to the abun a ce of overlapping c lls in one
region.) The quantitative PCR showed that th expression of hematopoi tic pr cursor genes (scl, gata1,
notch1a, notch1b, notch3, c-myb) were increased in the absence of Fer kinase activity (runx1 is decreased
early but recovers by 30 somites), while genes expressed in the vascular endothelium remained
generally unaffected (fli1, kdrl/flk1). The cell–cell adhesion complex component, cdh5 (VE-cadherin)
expression was unaffected in the absence of Fer kinase (I). (black bars indicate Fer MO at 8 somites,
gray bars indicate Fer MO at 28 somites, * indicate not done). The dotted line denotes the threshold for
up-regulated expression, when normalized to the wildtype expression levels, which was set at a value
of 1 on the y-axis.
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We then tested the hypothesis that the lack of circulating erythrocytes in the absence of Fer was
due primarily to defective vasculogenesis. By measuring different aspects of the trunk vasculature,
we determined that in fer-MO1 embryos, at 30 somites, there was a significant decrease in the diameter
of the dorsal aorta (DA) (Figure 5A, red arrows) and a loss of migrating cells into the intersegmental
vessel (ISV) region (Figure 5A, white arrowhead), when compared to control MO embryos at the
same stage (Figure 5B). Embryos lacking Fer kinase activity had a mean DA diameter of 4.93 µm,
compared to 17.03 µm for control MO injected embryos (Figure 5C, n = 7 per treatment, p = 1.91e−14).
Additionally, the number of cells migrating from the dorsal aorta into the region of the intersomitic
boundaries was 1.78 cells per ISV in fer-MO1 embryos, less than half as many as the control MO
embryos, which had 4.86 cells per ISV (Figure 5D, n = 25 per treatment, p = 1.42e−34).
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With a significantly smaller DA diameter and fewer cells migrating into the intersegmental
boundaries, we then asked whether the vasculature that did form in the trunk region was undergoing
tubulogenesis. We performed injections of a Rhodamine–Dextran conjugate into the dorsal aorta
and sinus venosus regions of morpholino injected embryos (fer and control). With the severity of the
disorganized posterior trunk vasculature using 0.5 mM fer-MO1, we titrated the MO concentration
and determined that at 1 nL of 0.25 mM MO we were able to observe a higher level of organization,
with a larger DA and more cells migrating in the intersegmental boundary regions (Figure 5E, control
MO—Figure 5F). Thus, we used this lower concentration of MO to determine whether, even in the
presence of increased normal vasculature organization, there was proper tube formation in the absence
of Fer kinase. In control MO injected embryos, we observed normal distribution of the Rhodamine dye
within fifteen minutes post-injection (n = 12) (Figure 5H). However, in the fer-MO1 injected embryos,
the dye never migrated beyond the area of injection, at up to one hour post-injection (n = 9) (Figure 5G).
Our results suggest that, even in the presence of vasculature and a beating heart, there is not a sufficient
amount of organized, open tubes within the trunk endothelium, to allow for proper circulation of
existing blood cells in the absence of Fer kinase function. (sinus venosus injection data resulted in
similar loss of dye circulation [37].
Using confocal microscopy we were able to support our previously observed phenotype by
showing that in the same embryo, the absence of Fer caused both defective DA/CV remodeling
and ISV cell migration (fli1a::nEGFP), as well as increased populations of gata1::dsRed expressing
cells in the DA (Figure 5J, control embryo—Figure 5I) (n = 10 per condition). By analyzing the
confocal images in a cross section, we were able to show that fer-MO1 embryos lacked gata1::dsRed
cells migrating through what is normally the lumen of the DA, in contrast to control MO injected
embryos (Figure 5J,I respectively, right panel). This data further supports the proposal that there are
no circulating hematopoietic cells due to improper tubulogenesis within the trunk vasculature.
Our data, showing either a loss of hemoglobin expressing erythrocytes, or a pooling of existing
erythrocytes, in addition to a lack of vascular organization, caused us to question whether there was a
shift in the number of cells within these populations in the absence of Fer. We tested this by performing
a fluorescence activated cell sorting (FACS) analysis with embryos containing both the fli1a::nEGFP
and gata1::dsRed expressing cells. fer-MO1 embryos were separated into the two categories of severity
described earlier, where one category of embryos had a pooling of hematopoietic cells and another,
more severe category contained no observable hematopoietic cells under white light microscopy.
Since the majority of embryos contained the pooled hematopoietic cells, we chose to use only those for
the FACS analysis.
To clarify the fluorescent populations, the gated regions, represented in Figure 4K, demonstrate
that we counted cell populations that reflected the expression of either fli1a (nEGFP) or gata1 (dsRed).
Since these are live cells, we could not avoid the fact that dsRed goes through an intermediate state
that fluoresces in the nEGFP spectrum while folding, and thus, appears to be both nEGFP and dsRed
positive [38,39]. However, because the cells contain a combination of dsRed and GFP-like fluorescence,
we were able to distinguish it from the fli-1a::nEGFP only population (Figure 5K). When we tested
injected embryos using a FACS analysis of the gated regions, the fer-MO1 embryos at 30 somites
showed a significant increase in the number of gata1::dsRed positive cells per embryo, from 203 in the
control embryos, to 244 in the fer-MO1 embryos (p = 0.013) and, conversely, no effective change in the
number of fli1a::nEGFP, from 294 cells per embryo in the control embryos, to 280 cells per embryo in
the absence of Fer (p = 0.17) (Figure 5L). Although this increase in cell number appears moderate, it is
reasonable based on previous studies examining the conversion of vascular precursors in the dorsal
aorta into erythrocytes [40]. Thus, we further investigated whether the endothelial cells are converted
to erythrocytes or there is excess proliferation within the erythrocyte population.
With a distinct link between the loss of differentiated erythrocytes and lack of proper
vasculogenesis, we next sought to determine whether there were gene expression changes in the
early genes that specify the direction of differentiation beyond the hemangioblast cell populations early
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in development. We examined the expression of erythrocyte determining genes at the 6 somite stage of
all embryos and found that gata1 and scl, both normally expressed in the lateral plate mesoderm, appear
to have slightly decreased levels and a discontinuous pattern in the fer-MO1 embryos (Figure 6B),
when compared to control MO embryos (Figure 6A) (n = 20/26 and 25/32 respectively). Although the
shape of the embryos appears wider, due to the convergent extension defects that lead to a shortening
along the anterior–posterior axis of the embryo, the overall expression levels of the gata1 and scl genes
appear to be mostly intact.Biology 2017, 6, 40 12 of 20 
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Figure 6. Fer kinase is required for proper expression patterns of hematopoietic genes. In situ
hybridization showed the expression of gata1, scl and runx1 at the 6 somite stage in the region of the
lateral plate mesoderm. Control embryos are shown in (A) while fer-MO1 embryos are shown in (B).
Arrows point to the region of runx1 expression. At 30 somites, the expressions of fli1 (C,D), gata1 (E–H),
scl (I–L), runx1 (M,N), c-myb (O,P), notch1b (Q,R), and hbbe2 (S,T) are shown.
However, when we examined expression of runx1, shown to be required for proper erythrocyte
development and vasculogenesis [41], we observed a severe decrease in the expression of the posterior
lateral plate mesoderm in the absence of Fer (n = 23/36) (Figure 6B) when compared to control embryos
(Figure 6A—black arrows).
Due to the altered nature in the expression of gata1, scl and runx1 earlier, we then examined the
later expression of genes involved in both vasculogenesis and hematopoiesis in the region of the ICM.
At 30 somites, the vascular endothelium marker, fli1, was expressed at normal levels but showed that
in 79.1 percent of fer-MO1 embryos there was a general lack of organization in the trunk region, with no
observable structural differentiation within the DA and CV regions, as well as no migrating ISV cells
(n = 34/43) (Figure 6D), when compared to control embryos at the same stage (n = 30) (Figure 6C).
Probes against hematopoietic genes, such as gata1 (n = 44/52) (Figure 6F,H), scl (n = 47/55)
(Figure 6J, L), c-myb (n = 34/41) (Figure 6P) and hbbe2 (n = 41/48) (Figure 6T) stained a larger population
of cells in the absence of Fer kinase, with the region of cells expressing these markers expanded in the
anterior direction (control MO is shown in Figure 6E,G (gata1), I,K (scl),O (c-myb),S (hbbe2) respectively),
suggesting either an up-regulation of expression with these genes or an increase in the number of
cells expressing these genes. We also observed a partial recovery of runx1 expression (n = 30/38)
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(Figure 6N), when compared to the control embryos (n = 40) (Figure 6M). We next examined each
of these genes using quantitative PCR and confirmed an increase in expression correlating to that
observed with our in situ hybridization analyses, with increases in expression, ranging from 1.5 to 2.5
fold, over control embryos at the same stage of development (Figure 4I). One notable exception was
that of runx1, which appears to be expressed at normal levels, which again, is in agreement with the in
situ hybridization results we observed.
The lack of migrating ISV cells during development suggested to us that there may be aberrant
Notch function in the absence of Fer, as Notch has been well known to regulate the formation of
ISVs [42,43]. Initially, we thought that perhaps an overexpression of a Notch signal might be responsible
for the defects related to the absence of Fer. We then investigated the expression levels of notch1a,
notch1b and notch3 during development in fer-MO1 embryos at two time points (8 somites and 28
somites) using quantitative PCR (Figure 4I). Surprisingly, notch3 expression was not altered; however,
levels of both notch1a and notch1b were both decreased by more than half the normal levels at 8 somites,
and elevated in excess of 1.5 fold at 28 somites. Thus, we examined notch1b via WISH and observed
that, consistent with our qPCR data, it was indeed up-regulated in the absence of Fer, when compared
to control MO embryos, in the trunk region (Figure 6R,Q, respectively) and the head [37].
3.3. Fer Kinase-Dependent and -Independent Activity during Development
To further investigate how Fer kinase functions during development, we tested whether the kinase
activity of Fer was required in specifying endothelium and hematopoietic cells. We generated two
separate point mutations that have previously been shown to effectively inactivate the kinase activity
of Fer in mice (SH2 and TyrKin mutations) and worms (TyrKin mutation) [12,16]. The first point
mutation was in the SH2 domain and changed a tryptophan to a cysteine, while the second and third
mutations converted an aspartic acid to an arginine, and lysine to arginine, respectively, in the tyrosine
kinase domain (Figure 7O, Western blot confirmation of protein expression shown in Supplementary
Figure S1). We then attempted to rescue the fer-deficient phenotypes by co-injecting fer-MO1 (0.25 mM)
with fer mRNA (wildtypes or containing either point mutation). It is important to note that we used
a cloned cDNA for fer, thus eliminating the possibility that the mRNA might be targeted by the
splice blocking MO (which exclusively targets an intron sequence). In three independent experiments,
wildtype fer mRNA was able to rescue both the vascular and hematopoietic defects in the absence of
endogenous Fer kinase activity, when compared to a control co-injection of fer-MO1 and fer anti-sense
mRNA (Supplementary Figure S2). The DA and ISV organization allowed for proper tubulogenesis to
take place, as injection with the rhodamine–dextran dye showed circulation throughout the embryo
(n = 9) (Figure 7B,E) compared to fer-MO1 alone (Figure 7A,D). Additionally, in situ hybridization
demonstrated that expression of hematopoietic directing genes such as runx1 (n = 29/33), gata1
(n = 32/37), and hbbe2 (n = 47/52) were restored to normal spatio–temporal expression patterns
(Figure 7H,K,N), when compared to fer-MO1 alone (Figure 7G,J,M).
Interestingly, both point mutants were able to rescue tubulogenesis within the vasculature,
with circulation of the Rhodamine-Dextran dye evident within fifteen minutes of injection (n = 12)
(Figure 7C,F—TyrKin (D744R) point mutant results shown only). However, neither of the Fer kinase
inactive point mutants (denoted as Fer KD) were able to rescue the hematopoietic cell population
defects, as evidenced by the fact that there was no significant difference between the fer-MO1 embryos
and the fer-MO1/fer mRNA (WT or KD) injected embryos, with respect to expanded expression of
runx1 (n = 25/31), gata1 (n = 23/28) and hbbe2 (n = 41/45) (Figure 7I,L,P). These data strongly suggest
that there are both kinase-dependent and independent functions to Fer that are required during normal
development in zebrafish. Specifically, we found that the Fer kinase-dependent activity was associated
with the expansion of erythrocyte gene expression, while the kinase-independent properties of Fer
were required in the organization of the vasculature.
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defects. The injection of fer mRNA and fer-MO1 into fli1a::nEGFP embryos results in increased cell
migration into the ISV regions ((B)—WT, (C)—kinase inactive (KD ) when compared to fer-MO1 alone
(A), and rescues tube formation (E)—WT, (F)—KD, Rhodamine-Dextran circulation after 15 min,
when compared to fer-MO1 alone (D)). Wild type Fer ameliorates defects in erythrocyte expansion,
as observed with runx1 (H), gata1 (K) and h be2 (N), while inactive Fer does not ((I,L,P) respectively).
fer-MO1 alone is shown in (G,J,M) respectively. Embryos were examined at 30 somites (~28 hpf).
Domains of Fer kinase in zebrafish, showing the highly conserved tryptophan and aspartic acid
residues, in the SH2 and tyrosine kinase domains, respectively, are shown. Mutating either tryptophan
to cysteine (W469C), aspartic acid to arginine (D744R) or lysine to arginine (K600R) resulted in the
loss of kinase activity for Fer. The amino acid sequence is shown on top, with the corresponding DNA
sequence changes below ((O), Fer KD expression confirmation shown in Supplementary Figure S1).
3.4. Fer Stabilizes Notch Signaling during Vasculogenesis but Not Hematopoiesis
Finally, due to the established links with Notch signaling, regulating both hematopoietic and
angiogenic signaling in ze rafish [44], along wi h our data showing increased expression of the
otch1b gene i the absence of Fer, we hypothesized that Fer functio s i regulating Notch signaling
during vasculogenesi and hematopoiesis. It has been shown that ncreased Notch activity suppresses
migration of endothelial cells into the ISV regions from the DA [45], as well as f cilitates expansion of
the growing erythrocyte populat ons [46]. Additionally, previous reports have demonstrated that the
absence of Fer d stabilizes cadherin omplexes, nd thus, cell–cell adhesions [16,21,24], which would
have a downstream effect on juxtacrine signaling. Knowing this, we tested our hypothesi that,
although e observed increase notch1 expression, a portion of the phenotype in the absence of Fer
could be due to the prevention of juxtacrine mediated Notch signaling as a potential consequence of
lost cell-cell adhesion.
Thus, we attempted to rescue the fer-MO1 phenotype, by activating Notch, regardless of cell–cell
adhesion. We co-injected mRNA expressing the activated form of Notch (NICD—Notch Intra-Cellular
Domain) along with mRNA expressing either wildtype or kinase inactive Fer (WT or KD) (NICD
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expression confirmed via Western analysis is shown in Supplementary Figure S1). After titrating
amounts of both NICD and fer mRNA, to eliminate non-specific, toxic effects, we found that injecting
10–15 pg of NICD mRNA with the control MO (0.5 mM) had no effect on the development of
hematopoietic cells or vasculogenesis (n = 52) (Figure 8A–C, respectively), as did injection with
the control MO alone (data not shown). Knocking down Fer function resulted in an expansion of
hematopoietic markers such as gata1 and scl (Figure 8M,N, respectively). Additionally, reduced Fer
function also inhibited ISV sprouting, as observed with fli1 expression (Figure 8O, arrowheads).
However, when co-injected with the fer-MO1 (0.5 mM), the activated form of Notch was able to
partially rescue vasculogenesis, as measured by the presence of fli1+ cells migrating into the ISV
region (58.7% rescue, n = 63) (Figure 8L—arrowheads), but had no effect on the hematopoietic gene
expression defect (87.2% defective, n = 55) (Figure 8J,K), suggesting that expansion of hematopoietic
cells requires Fer kinase activity, in addition to activated Notch. The ability of NICD to rescue
vascular endothelial cell organization was further enhanced when co-injected with the wildtype
version of Fer (82.7% rescue, n = 58) (Figure 8F), and was also sufficient to rescue the hematopoietic
gene expression defect (86.9% rescue, n = 61) (Figure 8D,E). Surprisingly, the NICD was also
able to rescue the Fer deficient vasculogenesis defect when co-injected with the kinase-inactive
Fer (Figure 8I) almost as effectively as with the wildtype Fer (76.6% rescue, n = 47), but not the
expanded hematopoietic gene expression (79.1% defective, n = 53) (Figure 8G,H). We were not able
to determine whether the erythrocyte gene expansion was primarily due to up-regulated Notch
mediated specification or hyperactivated proliferation. However, these results suggest that, in contrast
to hematopoietic populations, the vasculogenic organization events, via Notch activation, are either
enhanced, or stabilized, in the presence of Fer, regardless of Fer kinase activity.
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hematopoietic gene expression (79.1% defective, n = 53) (Figure 8G,H). We were not able to determine 
whether the erythrocyte gene expansion was primarily due to up-regulated Notch mediated 
specification or hyperactivated proliferation. However, these results suggest that, in contrast to 
hematopoietic populations, the vasculogenic organization events, via Notch activation, are either 
enhanced, or stabilized, in the presence of Fer, regardless of Fer kinase activity. 
 
Figure 8. Fer functions independently of Notch for erythrocyte population expansion but not 
intersomitic vessel formation. Co-injection of the Notch Intracellular Domain (NICD), along with 
wildtype (WT) or kinase-inactive (KD) Fer, showed that active Notch partially rescues vascular 
migration in the absence of Fer (fli1: (F)—WT, (I)—KD), but not excess erythrocyte proliferation (gata1: 
(D), WT, (G), KD; scl: (E), WT, (H), KD), when compared to fer-MO1 embryos containing only the 
NICD (J,K,L). Control MO embryos with injected NICD show normal gene expression of gata1 (A), 
scl (B) and fli1 (C). fer-MO1 alone—gata1 (M), scl (N) and fli1 (O). Embryos examined at 30 somites 
(~28 hpf). 
i Fer functions independently of Notch for erythrocyte o ulation ex ansion t t
i t rs itic ssel f ti . Co-injection of the otch I trace lular o ain ( I ), l it
il t ( ) -i cti e ( ) r, t i ti ll l r
i ration in the absence of Fer (fli1: (F)—WT, (I)—KD), but not excess er hrocyte proliferation
gata1: (D), WT, (G), KD; scl: (E), WT, (H), KD), when compared to fer-MO1 embryos containi g only
the NICD (J,K,L). Control MO embryos with inj cted NICD show normal gen expre sion of gata1 (A),
scl ( ) fli . ata ( ), l fl . i t i
( 28 hpf).
4. Discussion
The challenges in uncovering functions of Fer kinase during vertebrate development have
remained somewhat elusive, due to issues with obtaining a genomic knockout of the gene.
Biology 2017, 6, 40 15 of 20
Although evidence has been reported as to the function of Fer kinase during mouse development,
much of the data has been obtained using a kinase inactive knock-in version of the gene, which results
in viable mice, implying Fer may serve mainly in redundant roles during development [12]. We have
observed that in the absence of Fer kinase in zebrafish, embryonic development is arrested by 72 h post
fertilization, in agreement with what was previously reported by Paardekooper Overman, et al. [20].
Here we reported a novel defect with vasculogenesis and erythrocyte differentiation in the absence
of Fer kinase. Additionally, we demonstrated the presence of kinase-independent activity of
Fer, which may partially explain the viability of the knock-in, kinase inactive Fer mouse [12].
Furthermore, similar to our results, under normal conditions, Fer kinase expression has been observed
in hematopoietic precursors in mice [4]. The Fes/Fps kinase has been shown to redundantly regulate
hematopoiesis, along with Fer, through Stat5 and Erk [47]; however, the in vivo role of Fer in the
differentiation and proliferation of this cell type has not been previously characterized in developing
vertebrate embryos.
The role of Runx1 in zebrafish development has been well characterized, with the mutant being
initially reported to prevent both definitive hematopoiesis and vessel development [41], and more
recently runx1 was shown to be expressed in early hemogenic endothelial cells [48]. That study showed
a loss of circulation, due to improper vessel growth and an accumulation of erythrocyte precursors.
This is similar to what we observed in our experiments knocking down Fer kinase activity. It has
also been reported that Runx1 is tyrosine phosphorylated by Src family kinases in a manner that is
required for proper hematopoiesis to occur [49]. The similar phenotypes, linked by our data, showing
an early decrease, followed by a recovery of runx1 expression, suggest that there is a finely tuned
regulation of Runx1 function during development, possibly at the level of phosphorylation, if not by
gene expression levels.
Our experiments suggest that, in the absence of Fer, there is a defect in the Notch/Runx1
pathway, which results in an increase in gata1 and c-myb expression, and a concomitant increase
in erythrocytes. This finding is supported by data in which Cai et al. reported that an AML (Runx1)
haploinsufficent mouse model resulted in the early emergence of hematopoietic stem cells [50].
Furthermore, a conditional Runx1 deletion in mice resulted in the depletion of later emerging, adult
hematopoietic stem cell populations [51]. Since Notch activates Runx1, it could be that, in the absence
of Fer, the normal ratio of hematopoietic and endothelial precursors in later embryos is shifted, in this
case due to a hyperactive Notch signal that enhanced the number of erythrocytes at the expense of
endothelium prior to the onset of definitive hematopoiesis, a model suggested by [52]. However,
our results show that there is an increase in the erythrocyte gene expression without a corresponding
major decrease in vascular endothelial cells, similar to the increase in hematopoietic stem cell marker
production with the overexpression of the NICD, reported by Burns et al. [44].
Although we could not conclude whether it was expanded, the determination versus proliferation
of erythrocyte precursors in the absence of Fer, supported a cellular proliferation role, rather than
specification, as it has been previously shown in that Fer kinase is required for proper cell cycle control
in models ranging from nematode endoderm proliferation and seam cell division [26,27] to acute
myeloid leukemia cell lines [53]. Thus, it is possible that under normal conditions during development,
Fer plays a role in regulating the expansion of the trunk hematopoietic cells via Notch signaling.
In the absence of Fer kinase activity, we observed that proper heart development was arrested
with the presence of non-circulating erythrocytes, in both heart chambers, along with pericardial
edema (Figure 2B–H), which is similar to what was reported by Mitchell, et al. with the knockdown
of VE–cadherin in zebrafish [54]. However, since our data showed that the knockdown of Fer kinase
caused severe defects in the trunk vasculature, which was not observed with the knockdown of
VE–cadherin in Mitchell, et al., it is likely that the fer-MO1 defect is not through decreased cadherin
expression (Figure 4I), but in the destabilization of cadherin-mediated adhesion complexes. A critical
role for Fer in stabilizing cadherin complexes during development has been previously shown with Fer
homologues in both nematodes and flies [16,24]. In parallel with cadherin complex stability, the defect
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we observed could also be due to a migration defect that is dependent on integrin complexes between
the plasma membrane and the extracellular matrix used by migrating ISV cells as they move along the
intersomitic boundaries. In fact, it has been reported that both Fes/Fps kinase family members and
integrin linked kinases (ILK) regulate survival and migration in vascular endothelium, during mouse
and zebrafish development, respectively [55,56]. Thus, it is reasonable to hypothesize that Fer kinase
mediates activity in the switch from adhesion to migration, as it has previously been shown to engage
in cross-talk between cadherin and integrin complexes [33,57].
Although we observed an increase in notch1 expression, endogenous Notch activity may be
abrogated by a loss of cell–cell adhesion, as occurs with the loss of cadherin complex stability in the
absence of Fer [16,24], which would disrupt juxtacrine dependent processes. It is also possible that
the loss of hematopoietic cells that we observed with Fer knockdown is due to blockage of circulatory
flow, such as has been reported by North et al. [58]. Alternatively, it could be that Fer functions,
in part, to regulate the emergence of hematopoietic gene expression, which would be consistent with
the expression of notch1b and emergence of HSCs, reported by Kim et al. [59], and that even in the
absence of flow, those genes can be activated. However, the vasculogenesis defects we observed in Fer
deficient embryos are similar to that reported in the absence of gridlock, a gene downstream of Notch
that is required for proper vasculogenesis during zebrafish development [43]. Furthermore, Notch
signaling normally acts to regulate angiogenic behavior, such that when Notch activity is lost, there is
excess proliferation and migration within the endothelial cell lineage [45,60]. More recently, it was
shown that notch1b promotes arterial cell fate and prevents tip cell fate, thus sprouting into the ISV
from the DA [61]. Our observation that in the absence of Fer kinase, there was a lack of endothelial
cell migration out of the DA, combined with an overexpression of notch1b, suggests a role for Fer in
regulating vascular cell migration. Two likely possibilities in which the absence of Fer would allow
the overexpression of Notch in the DA are: (1) suppressed endothelial fates, thereby facilitating a
switch to hematopoietic fate, or (2) excess Notch simply prevents initial migration into the ISVs and
the hematopoietic expansion occurs in a distinct manner, separate from endothelial cell migration.
Any migrating cells moving into the ISVs, however, would likely not be stabilized, due to a potential
loss of cell–cell contacts (normally stabilized via Fer).
Finally, the emergence of kinase inactive roles for many protein kinases has become an intriguing
topic in recent years. In the case of Fer, the finding that a kinase inactivating knock-in allows
sufficient function for development and viability in mice suggests kinase-independent roles for Fer [12].
Although it is possible that defects observed in the absence of Fer are primarily due to the loss of
cell adhesion, combined with up-regulation of Notch1, our data also suggest kinase-dependent and
independent roles of Fer, which are distinct along the lines of erythrocyte expansion and endothelial
adhesion/migration. We suggest a kinase active role for Fer that regulates expansion of erythrocyte
precursors, which is enhanced in the presence of activated Notch. Additionally, a kinase inactive
function of Fer is necessary in organizing the vasculature, by regulating the Notch signaling that
facilitates migrating ISV cells.
The concept of a balance in Fer kinase activity has been supported in other studies, such as
over-expression data in metastatic breast cancer and gain of function mutation data from fruit
flies [24,62]. In both cases, excess Fer kinase activity destabilized cell–cell adhesion and promoted a
disorganized migration of cells, suggesting there is an optimum range of Fer activity that is critical to
proper cell function. However, neither study examined the possibility that Fer may function, at least
partially, in a kinase-independent manner. This additional function was later shown to be present in
both mice [12] and nematodes [16].
5. Conclusions
Taken together, our results suggest that Fer kinase activity regulates a finely tuned balance that,
when lost, results in an increase in the erythrocyte population, while at the same time, exerts a kinase
independent function that facilitates cellular organization in the vascular endothelium. This function
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of Fer is likely through stabilization of adhesion complexes at the plasma membrane, such as cadherin
and integrin complexes, which mediates critical juxtacrine signaling mechanisms. Future studies will
likely identify the protein interactions for Fer, which will further clarify the phosphorylation events in
proliferation activity as well as kinase-independent, direct interactions facilitating cell–cell adhesion
in the regulation of juxtacrine mechanisms, such as the Notch pathway, in vascular endothelial
cell migration.
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Fer Kinase control MO—arrest of proper heart looping along with pericardial edema.
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